Clinical Trial

Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

Completed
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a clinical setting. The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-02; most recent amendment 2026-01-26.
Status change: Active, Not Recruiting → Completed 2026-01-26
Status change: Recruiting → Active, Not Recruiting 2025-11-17
Trial Details
NCT Number NCT07050875
Lead Sponsor ABLE Human Motion S.L.
Collaborators: Centro Europeo de Neurociencias (CEN), Cefine Neurología (CEFINE), Fundación Step by Step (SBS)
Conditions Acquired Brain Injury (Including Stroke)
Enrollment 14 participants
Start Date 2025-06-30
Primary Completion 2025-12-17 (estimated)
Study Completion 2025-12-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-27